<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27438806</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>02</Month>
            <Day>05</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-1920</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>58</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Neuroradiology</Title>
                <ISOAbbreviation>Neuroradiology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1027-1034</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Based on clinical observations, we hypothesized that in infiltrative high-grade brainstem neoplasms, such as diffuse intrinsic pontine glioma (DIPG), longitudinal metabolic evaluation of the tumor by magnetic resonance spectroscopy (MRS) may be more accurate than volumetric data for monitoring the tumor's biological evolution during standard treatment.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We evaluated longitudinal MRS data and corresponding tumor volumes of 31 children with DIPG. We statistically analyzed correlations between tumor volume and ratios of Cho/NAA, Cho/Cr, and NAA/Cr at key time points during the course of the disease through the end of the progression-free survival period.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">By the end of RT, tumor volume had significantly decreased from the baseline (P &lt; .0001) and remained decreased through the last available follow-up magnetic resonance imaging study (P = .007632). However, the metabolic profile of the tumor tissue (Cho/Cr, NAA/Cr, and Cho/NAA ratios) did not change significantly over time.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our data show that longitudinal tumor volume and metabolic profile changes are dissociated in patients with DIPG during progression-free survival. Volume changes, therefore, may not accurately reflect treatment-related changes in tumor burden. This study adds to the existing body of evidence that the value of conventional MRI metrics, including volumetric data, needs to be reevaluated critically and, in infiltrative tumors in particular, may not be useful as study end-points in clinical trials. We submit that advanced quantitative MRI data, including robust, MRS-based metabolic ratios and diffusion and perfusion metrics, may be better surrogate markers of key end-points in clinical trials.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Löbel</LastName>
                    <ForeName>U</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Diagnostic Imaging, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS220, Memphis, TN, 38105, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hwang</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Diagnostic Imaging, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS220, Memphis, TN, 38105, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Edwards</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Diagnostic Imaging, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS220, Memphis, TN, 38105, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>X</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Broniscer</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patay</LastName>
                    <ForeName>Z</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Diagnostic Imaging, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS220, Memphis, TN, 38105, USA. zoltan.patay@stjude.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 CA021765</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>07</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Neuroradiology</MedlineTA>
            <NlmUniqueID>1302751</NlmUniqueID>
            <ISSNLinking>0028-3940</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>30KYC7MIAI</RegistryNumber>
                <NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>997-55-7</RegistryNumber>
                <NameOfSubstance UI="C000179">N-acetylaspartate</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>MU72812GK0</RegistryNumber>
                <NameOfSubstance UI="D003401">Creatine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N91BDP6H0X</RegistryNumber>
                <NameOfSubstance UI="D002794">Choline</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020295" MajorTopicYN="N">Brain Stem Neoplasms</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002794" MajorTopicYN="N">Choline</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003401" MajorTopicYN="N">Creatine</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057054" MajorTopicYN="N">Molecular Imaging</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment (Health Care)</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D047368" MajorTopicYN="N">Tumor Burden</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Brainstem tumor</Keyword>
            <Keyword MajorTopicYN="N">Diffuse intrinsic pontine glioma</Keyword>
            <Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword>
            <Keyword MajorTopicYN="N">Proton spectroscopy</Keyword>
            <Keyword MajorTopicYN="N">Response criteria</Keyword>
        </KeywordList>
        <CoiStatement>AB received partial financial support from AstraZeneca to conduct this clinical trial.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>03</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>07</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>10</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>2</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27438806</ArticleId>
            <ArticleId IdType="pmc">PMC5071138</ArticleId>
            <ArticleId IdType="doi">10.1007/s00234-016-1724-8</ArticleId>
            <ArticleId IdType="pii">10.1007/s00234-016-1724-8</ArticleId>
            <ArticleId IdType="mid">NIHMS804763</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Pediatr Blood Cancer. 2013 Sep;60(9):1397-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23625747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroimage. 2004 Oct;23(2):454-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15488395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1979 Oct;44(4):1256-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">387205</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuro Oncol. 2011 Apr;13(4):417-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21297126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1983 Dec 15;52(12):2313-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6640503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):20-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15850898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Radiol. 2009 Dec;39(12):1317-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19657635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuro Oncol. 2011 Aug;13(8):904-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21757444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Nov 1;28(31):4762-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20921456</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1990 Jul;8(7):1277-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2358840</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1986 Apr;19(4):373-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3707089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2013 Jul;34(7):1450-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23436052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Apr 10;28(11):1963-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20231676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurooncol. 2011 Nov;105(2):365-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21567301</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2006 Apr;27(4):806-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16611768</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Oncol. 2006 Mar;7(3):241-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16510333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):774-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22445531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 1987 Jun;62(6):450-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3553757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2004 Jul;232(1):221-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15220505</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Clin Pharmacol. 2011 Mar;4(2):233-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21666852</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 2004;129(4):1011-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15561416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14625221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Magn Reson Imaging. 2005 Jun;21(6):701-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15906339</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AJNR Am J Neuroradiol. 2005 Oct;26(9):2170-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16219818</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuro Oncol. 2016 May;18(5):725-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26487690</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuro Oncol. 2011 Jul;13(7):791-801</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21653595</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 1996 Sep 15;98(6):1400-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8823305</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurooncol. 2008 Feb;86(3):313-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17909941</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurooncol. 2000 Oct-Nov;50(1-2):109-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11245271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosurg. 1986 Jan;64(1):11-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3941334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuro Oncol. 2008 Feb;10(1):32-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18003889</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Neurosurg. 1996;24(4):185-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8873160</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>